Conference Call and Webcast to Follow
WASHINGTON, Feb. 5, 2025
/PRNewswire/ -- Vanda Pharmaceuticals Inc. (Vanda) (Nasdaq: VNDA)
today announced it will release results for the fourth quarter and
full year 2024 on Thursday, February 13,
2025, after the market closes.
Vanda will host a conference call at 4:30 PM ET on Thursday, February 13, 2025, during which
management will discuss the fourth quarter and full year 2024
financial results and other corporate activities. To participate in
the conference call, please dial 1-800-715-9871 (domestic) or
1-646-307-1963 (international) and use passcode 2881765.
The conference call will be broadcast simultaneously and
archived on Vanda's website, www.vandapharma.com. Investors should
go to the website at least 15 minutes early to register, download,
and install any necessary audio software.
A replay of the call will be available on Thursday, February 13, 2025, beginning at
8:30 PM ET and will be accessible
until Thursday, February 20, 2025, at
11:59 PM ET. The replay call-in
number is 1-800-770-2030 for domestic callers and
1-609-800-9909 for international callers. The passcode number is
2881765.
About Vanda Pharmaceuticals Inc.
Vanda is a leading global biopharmaceutical company focused on
the development and commercialization of innovative therapies to
address high unmet medical needs and improve the lives of patients.
For more on Vanda Pharmaceuticals Inc., please visit
www.vandapharma.com and follow us on X @vandapharma.
Corporate Contact:
Kevin Moran
Senior Vice President, Chief Financial Officer and
Treasurer
Vanda Pharmaceuticals Inc.
202-734-3400
pr@vandapharma.com
Jim Golden / Jack Kelleher / Dan
Moore
Collected Strategies
VANDA-CS@collectedstrategies.com
View original content to download
multimedia:https://www.prnewswire.com/news-releases/vanda-pharmaceuticals-to-announce-fourth-quarter-and-full-year-2024-financial-results-on-february-13-2025-302369401.html
SOURCE Vanda Pharmaceuticals Inc.
